Literature DB >> 18342795

Polymorph control: past, present and future.

Antonio Llinàs1, Jonathan M Goodman.   

Abstract

The appearance and disappearance of polymorphs is no longer a mysterious and inexplicable process. Although methods for polymorph control are still imperfect, there is a large armoury of methods that can be used to tackle this important and challenging problem. We survey the methods and their successes over the last few years.

Mesh:

Substances:

Year:  2008        PMID: 18342795     DOI: 10.1016/j.drudis.2007.11.006

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  28 in total

1.  Hidden polymorphs drive vitrification in B2O3.

Authors:  Guillaume Ferlat; Ari Paavo Seitsonen; Michele Lazzeri; Francesco Mauri
Journal:  Nat Mater       Date:  2012-09-02       Impact factor: 43.841

2.  Physicochemical investigations and stability studies of amorphous gliclazide.

Authors:  Shital Jondhale; Satish Bhise; Yogesh Pore
Journal:  AAPS PharmSciTech       Date:  2012-03-02       Impact factor: 3.246

3.  Multicomponent chemical imaging of pharmaceutical solid dosage forms with broadband CARS microscopy.

Authors:  Christopher M Hartshorn; Young Jong Lee; Charles H Camp; Zhen Liu; John Heddleston; Nicole Canfield; Timothy A Rhodes; Angela R Hight Walker; Patrick J Marsac; Marcus T Cicerone
Journal:  Anal Chem       Date:  2013-08-20       Impact factor: 6.986

Review 4.  An overview of famotidine polymorphs: solid-state characteristics, thermodynamics, polymorphic transformation and quality control.

Authors:  Shan-Yang Lin
Journal:  Pharm Res       Date:  2014-03-01       Impact factor: 4.200

5.  4-Aminoquinaldine monohydrate polymorphism: Prediction and impurity aided discovery of a difficult to access stable form.

Authors:  Doris E Braun; Herbert Oberacher; Kathrin Arnhard; Maria Orlova; Ulrich J Griesser
Journal:  CrystEngComm       Date:  2015-10-15       Impact factor: 3.545

6.  Solid state forms of 4-aminoquinaldine - From void structures with and without solvent inclusion to close packing.

Authors:  Doris E Braun; Thomas Gelbrich; Volker Kahlenberg; Ulrich J Griesser
Journal:  CrystEngComm       Date:  2015-03-28       Impact factor: 3.545

7.  Absorbing a Little Water: The Structural, Thermodynamic, and Kinetic Relationship between Pyrogallol and Its Tetarto-Hydrate.

Authors:  Doris E Braun; Rajni M Bhardwaj; Jean-Baptiste Arlin; Alastair J Florence; Volker Kahlenberg; Ulrich J Griesser; Derek A Tocher; Sarah L Price
Journal:  Cryst Growth Des       Date:  2013-07-24       Impact factor: 4.076

8.  Experimental and Computational Hydrate Screening: Cytosine, 5-Flucytosine and Their Solid Solution.

Authors:  Doris E Braun; Volker Kahlenberg; Ulrich J Griesser
Journal:  Cryst Growth Des       Date:  2017-06-13       Impact factor: 4.076

9.  Molecular Level Understanding of the Reversible Phase Transformation between Forms III and II of Dapsone.

Authors:  Doris E Braun; Hannes Krüger; Volker Kahlenberg; Ulrich J Griesser
Journal:  Cryst Growth Des       Date:  2017-09-12       Impact factor: 4.076

10.  Why do Hydrates (Solvates) Form in Small Neutral Organic Molecules? Exploring the Crystal Form Landscapes of the Alkaloids Brucine and Strychnine.

Authors:  Doris E Braun; Ulrich J Griesser
Journal:  Cryst Growth Des       Date:  2016-11-02       Impact factor: 4.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.